Cargando…
Implanting 1.1B4 human β-cell pseudoislets improves glycaemic control in diabetic severe combined immune deficient mice
AIM: To investigate the potential of implanting pseudoislets formed from human insulin-releasing β-cell lines as an alternative to islet transplantation. METHODS: In this study, the anti-diabetic potential of novel human insulin releasing 1.1B4 β-cells was evaluated by implanting the cells, either a...
Autores principales: | Green, Alastair D, Vasu, Srividya, McClenaghan, Neville H, Flatt, Peter R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107712/ https://www.ncbi.nlm.nih.gov/pubmed/27895821 http://dx.doi.org/10.4239/wjd.v7.i19.523 |
Ejemplares similares
-
Overexpression of the malate–aspartate NADH shuttle member Aralar1 in the clonal β-cell line BRIN-BD11 enhances amino-acid-stimulated insulin secretion and cell metabolism
por: Bender, Katrin, et al.
Publicado: (2009) -
Differential Acute and Long Term Actions of Succinic Acid Monomethyl Ester Exposure on Insulin-Secreting BRIN-BD11 Cells
por: Picton, Sally F., et al.
Publicado: (2001) -
Stem Cell-Based Approaches for the Treatment of Diabetes
por: Kelly, Catriona, et al.
Publicado: (2011) -
In Vitro Formation of β Cell Pseudoislets Using Islet-Derived Endothelial Cells
por: Spelios, Michael G., et al.
Publicado: (2013) -
The Modified Stenver’s View for Cochlear Implants – What do the Surgeons Want to Know?
por: McClenaghan, Fiona, et al.
Publicado: (2020)